T&S Products, Inc. – Trademark Portfolio
Entity Type: 03
T&S Products, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include OVAFIT and PURELY PRENATAL. The owner is based in Arlington, TX.
525 Duncan Perry Road
Arlington, TX 76011
Showing of trademarks Trademarks
Trademark Classifications
T&S Products, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does T&S Products, Inc. have?
T&S Products, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned, 1 cancelled.
What trademark classes does T&S Products, Inc. file in?
T&S Products, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods), Class 17 (Rubber Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are T&S Products, Inc.'s most well-known trademarks?
T&S Products, Inc.'s registered trademark portfolio includes well-known marks such as OVAFIT and PURELY PRENATAL. These are among 2 currently registered trademarks in the portfolio.
What is T&S Products, Inc.'s trademark registration success rate?
T&S Products, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.